Key result
Jetstream atherectomy in P2/P3 popliteal segments yields similar distal embolization risk to SFA/P1.
Why the study?
Endovascular treatment of mid- and distal popliteal artery (P2/P3) lesions is challenging due to repetitive mechanical deformation and concerns about permanent stenting, and data on the procedural safety and clinical outcomes of Jetstream atherectomy in these segments are limited.
Does extending Jetstream atherectomy to the P2/P3 popliteal artery segments affect periprocedural safety (including distal embolization) and 1-year patency compared to treatment limited to the SFA/P1 segments in patients with femoropopliteal artery lesions?
Cohort (n=381)
Yes
Does extending Jetstream atherectomy to the P2/P3 popliteal artery segments affect periprocedural safety (including distal embolization) and 1-year patency compared to treatment limited to the SFA/P1 segments in patients with femoropopliteal artery lesions?
Extending Jetstream atherectomy to the P2/P3 popliteal artery segments showed comparable 1-year patency and overall periprocedural safety to SFA/P1 treatment when frequently paired with distal protection, though numerically higher rates of distal embolization requiring intervention warrant caution.
Answers are grounded in this paper and cite their sources.
Extending Jetstream atherectomy to P2/P3 segments was not associated with increased distal embolization; leaves open prospective randomized confirmation before practice change.
BACKGROUND: Endovascular treatment of mid- and distal popliteal artery (P2/P3) lesions remains challenging owing to repetitive mechanical deformation and concerns regarding permanent stent implantation. In this setting, Jetstream atherectomy may facilitate lesion preparation; however, data on its use in the P2/P3 segments, procedural safety, and clinical outcomes remain limited. METHODS: We retrospectively analyzed 443 limbs of 381 patients who underwent Jetstream atherectomy for femoropopliteal artery lesions in a multicenter registry. Limbs were classified by the most distal segment treated with Jetstream into the SFA/P1 and P2/P3 groups. The primary outcomes were procedural characteristics and periprocedural safety, including distal embolization (DE). Secondary outcomes were 1-year primary patency (PP) and freedom from clinically driven target-lesion revascularization (CD-TLR). RESULTS: The Jetstream atherectomy was extended to the P2/P3 segments in 94 limbs (21.2%). Distal protection was more frequently used in the P2/P3 group (90.4% vs. 80.8%, p = 0.035). Overall DE occurred in 37.2% of the P2/P3 group and 33.8% of the SFA/P1 group (p = 0.51), whereas DE requiring endovascular intervention was numerically more frequent in the P2/P3 group (9.6% vs. 4.6%, p = 0.067). Jetstream use extending to the P2/P3 segments was not independently associated with overall DE (adjusted odds ratio 1.22, 95% CI 0.72-2.07; p = 0.47). At 1 year, PP was 84.4% in the P2/P3 group and 85.0% in the SFA/P1 group (p = 0.74), whereas freedom from CD-TLR was 89.9% and 90.8%, respectively (p = 0.50). CONCLUSIONS: Jetstream atherectomy extended to the P2/P3 segments in approximately one-fifth of the treated limbs, with more frequent use of distal protection. Although no clear differences in periprocedural complications or 1-year clinical outcomes were observed, careful attention to DE is warranted.
No takes yet. Share an insight, caveat, or question.
Yoshioka et al. (2026) conducted a cohort in Femoropopliteal artery lesions (n=381). Jetstream atherectomy extending to the P2/P3 popliteal artery segments vs. Jetstream atherectomy limited to the SFA/P1 segments was evaluated on Procedural characteristics and periprocedural safety, including distal embolization (DE) (OR 1.22, 95% CI 0.72-2.07, p=0.47). Jetstream atherectomy extending to P2/P3 segments had similar distal embolization and 1-year patency compared with SFA/P1.
Synapse has enriched 10 related papers. Consider them for comparative context: